Other growth factors, e.g. hepatocyte growth factor (HGF) 15 and insulin growth factor-II (IGF-II) 16, have also been reported to be expressed at increased levels in ESCC patients and to correlate with poor survival. This evidence concerns the gene HGF and esophageal squamous cell carcinoma.